Mary Kay Turner

Mary Kay Turner has spent her professional career in the biopharma industry in Government Affairs, Advocacy and Health policy. Her most recent position was the head of Public Affairs for Mitsubishi Tanabe Pharma America leading the commercialization of a compound for ALS (Amyotrophic Lateral Sclerosis). Mary Kay joined BrainStorm in August of 2017 as Vice President of Patient Advocacy and Government Affairs. She is a government affairs executive with political action and legislative/advocacy /regulatory expertise.

Mary Kay’s most rewarding experiences throughout her career have been in working in areas of high unmet medical need. During her work in ALS, she was struck by the people and caregivers she met with ALS. She is inspired by the healthcare practitioners and researchers who have dedicated their lives to changing the course for this devastating condition.

In 2016, Mary Kay was appointed to the Arizona Biomedical research Commission by Government Doug Ducey and served a one-year term. She is also on the Board of Advisers for the International Cancer Advocacy Network. Prior, Mary Kay served on the Board of Directors for Mental Health America for 5 years. Mary Kay has a Bachelor of Arts degree in Political Science and History from the University of Oregon.